Carbidopa

Type: Keyphrase

Name: Carbidopa

First reported May 14 2013 - Updated May 14 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet, Extended Release [Accord Healthcare, Inc.]

Updated Date: May 9, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]

Entities: Carbidopa, Accord Healthcare

First reported May 09 2013 - Updated May 09 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet, Extended Release [Accord Healthcare, Inc.]

Updated Date: May 9, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]

Entities: Carbidopa, Accord Healthcare

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet [Cardinal Health]

Updated Date: Apr 26, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 26 2013]

Entities: Carbidopa, Cardinal Health Inc

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet [Preferred Pharmaceuticals, Inc]

Updated Date: Apr 25, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 25 2013]

Entities: Carbidopa

First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet [Preferred Pharmaceuticals, Inc.]

Updated Date: Apr 24, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 24 2013]

Entities: Carbidopa

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Cardinal Health Inc

CARBIDOPA AND LEVODOPAtablet [Cardinal Health]

Updated Date: Apr 23, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 23 2013]

Entities: Carbidopa, Cardinal Health Inc

First reported Apr 15 2013 - Updated Apr 16 2013 - 5 reports

Phase II

NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug fo...

NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its Phase IIa clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula under development ... [Published BioMedReports - Apr 15 2013]

Entities: L-Dopa, Parkinson's Disease, Carbidopa, Drugs, Phase II

First reported Apr 10 2013 - Updated Apr 10 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet, Extended Release [Apotex Corp.]

Updated Date: Apr 10, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 10 2013]

Entities: Carbidopa, Apotex

First reported Mar 29 2013 - Updated Mar 29 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ]

Updated Date: Mar 29, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 29 2013]

Entities: Carbidopa

First reported Mar 26 2013 - Updated Mar 26 2013 - 2 reports

CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ]

Updated Date: Mar 26, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 26 2013]

Entities: Carbidopa

First reported Mar 15 2013 - Updated Mar 15 2013 - 1 reports

CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ]

Updated Date: Mar 15, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 15 2013]

Entities: Carbidopa

First reported Feb 28 2013 - Updated Mar 01 2013 - 2 reports

CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ]

Updated Date: Mar 1, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 01 2013]

Entities: Carbidopa

Quotes

"Following its success in phase I trials, ND0612 is now entering trials in patients. An important objective of this study will be to find out what steady state levodopa concentrations can be reached in patients. In healthy volunteers, ND0612 reached day and night steady state levodopa levels, the elusive holy grail of Parkinson's levodopa therapy, in a conveniently administered drug that should be available to all PD patients. Moreover, ND0612 bypasses the gastrointestinal tract and should be little influenced by intestinal absorption or oral ingestion of food or drugs. This trial marks a landmark in the development of ND0612, a novel levodopa drug that could become a breakthrough treatment option in Parkinson's Diseases."

NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug ... [Published BioMedReports - Apr 15 2013]

More Content

sort by: Date \| Relevance
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): T... [Published InsiderMonkey.com - May 15 2013]
2 Scariest Dividend Stocks in Health Care [Published Motley Fool - May 15 2013]
CARBIDOPA AND LEVODOPAtablet, Extended Release ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
CARBIDOPA AND LEVODOPAtablet, Extended Release ... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
CARBIDOPA AND LEVODOPAtablet [Cardinal Health] [Published DailyMed Drug Label Updates for the last seven ... - Apr 26 2013]
CARBIDOPA AND LEVODOPAtablet [Preferred Pharmac... [Published DailyMed Drug Label Updates for the last seven ... - Apr 25 2013]
CARBIDOPA AND LEVODOPAtablet [Preferred Pharmac... [Published DailyMed Drug Label Updates for the last seven ... - Apr 24 2013]
CARBIDOPA AND LEVODOPAtablet [Cardinal Health] [Published DailyMed Drug Label Updates for the last seven ... - Apr 23 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published BioMedReports - Apr 15 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published 9&10 News - Apr 15 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published Phoenix Business Journal - Apr 15 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published Yahoo! Finance - Apr 15 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published FinanzNachrichten.de - Apr 15 2013]
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published PR Newswire: Health - Apr 15 2013]
CARBIDOPA AND LEVODOPAtablet, Extended Release ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 10 2013]
CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ] [Published DailyMed Drug Label Updates for the last seven ... - Mar 29 2013]
CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ] [Published DailyMed Drug Label Updates for the last seven ... - Mar 26 2013]
CARBIDOPA AND LEVODOPAtablet, Extended Release ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 26 2013]
CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ] [Published DailyMed Drug Label Updates for the last seven ... - Mar 15 2013]
CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ] [Published DailyMed Drug Label Updates for the last seven ... - Mar 01 2013]
CARBIDOPA AND LEVODOPAtablet [REMEDYREPACK INC. ] [Published DailyMed Drug Label Updates for the last seven ... - Feb 28 2013]
CARBIDOPA AND LEVODOPAtablet [NCS HealthCare Of... [Published DailyMed Drug Label Updates for the last seven ... - Feb 26 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 07 2013]

Blogs

sort by: Date \| Relevance
CARBIDOPA AND LEVODOPAtablet, Extended Release ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013] Updated Date: May 9, 2013 EST ...
CARBIDOPA AND LEVODOPAtablet, Extended Release ... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013] Updated Date: May 9, 2013 EST ...
CARBIDOPA AND LEVODOPAtablet [Cardinal Health] [Published DailyMed Drug Label Updates for the last seven ... - Apr 26 2013] Updated Date: Apr 26, 2013 EST ...
CARBIDOPA AND LEVODOPAtablet [Preferred Pharmac... [Published DailyMed Drug Label Updates for the last seven ... - Apr 25 2013] Updated Date: Apr 25, 2013 EST ...
CARBIDOPA AND LEVODOPAtablet [Preferred Pharmac... [Published DailyMed Drug Label Updates for the last seven ... - Apr 24 2013] Updated Date: Apr 24, 2013 EST ...

Press Releases

sort by: Date \| Relevance
NeuroDerm Announces Enrollment in a Phase 2 Stu... [Published PR Newswire: Health - Apr 15 2013]